The impact of the presence of youngsters on grownup smoking behaviour: empirical proof primarily based on China household panel research
Background: Regardless of various research linking household and marriage components with well being behaviour, the consequences of youngsters on the well being behaviour of oldsters are nonetheless understudied. This research explored the affiliation between the presence of youngsters and adults’ smoking behaviours.
Strategies: This research used panel information from the China Household Panel Research 2010 and 2012, and the info set included 23,157 households and 45,513 adults. Logistic regression was carried out to analyse the affiliation of the presence of youngsters on adults’ smoking behaviours. Subgroup regression was used to look at heterogeneous results.
Outcomes: Full pattern regressions confirmed that the variety of youngsters was considerably inversely related to smoking behaviour (OR = 0.93; 95% 0.90-0.96). Additional subsample regression finds that such impact is barely vital among the many high-education group (OR = 0.92; 95% 0.87-0.97), high-skill staff (OR = 0.89; 95% 0.80-0.99) and {couples} who had an age hole better than 2 years (OR = 0.91; 95% 0.88-0.95).
Conclusions: Our findings verify the existence of the upward intergenerational impact of the presence of youngsters on adults’ smoking behaviour in China. Nonetheless, such results will not be equal throughout all demographic traits. Future analysis may discover different elements of the upward mechanism and potential pathways for a stronger impact. In resource-poor areas, focusing on cessation actions at those that have youngsters at an early age could also be an efficient technique.
Mouse Monoclonal Anti-Gardasil vaccine L1s (Human Papilloma Virus/HPV6+11+16+18 late proteins) antiserum control for ELISA |
|||
| HPV618L13-S | Alpha Diagnostics | 1 ml | 562.8 EUR |
Rabbit Anti-Gardasil vaccine (merck) antiserum (Human Papilloma Virus 16+18 (HPV16/18) late proteins L1 (HPV16+18L1) control for ELISA |
|||
| HPV16181-S | Alpha Diagnostics | 500 ul | 562.8 EUR |
Human Anti-Merozoite surface protein-1 (MSP-1; P. falciparum/malaria vaccine) IgG antiserum negative control |
|||
| 970-360-01N | Alpha Diagnostics | 1 ml | 196.8 EUR |
Human Anti-Merozoite surface protein-1 (MSP-1; P. falciparum/malaria vaccine) IgG antiserum positive control |
|||
| 970-360-02P | Alpha Diagnostics | 1 ml | 270 EUR |
Human Anti-Merozoite surface protein-1 (MSP-1; P. falciparum/malaria vaccine) IgM antiserum negative control |
|||
| 970-370-01N | Alpha Diagnostics | 1 ml | 196.8 EUR |
Human Anti-Merozoite surface protein-1 (MSP-1; P. falciparum/malaria vaccine) IgM antiserum positive control |
|||
| 970-370-02P | Alpha Diagnostics | 1 ml | 270 EUR |
Labcold Gel Pack for Vaccine Transport Bag - EACH |
|||
| REF4120 | Scientific Laboratory Supplies | EACH | 5.92 EUR |
BCG vaccine |
|||
| VAC-0001 | Creative BioMart | 0.5ml | 2398.4 EUR |
|
Description: Protein |
|||
rsPSMA Vaccine |
|||
| NG2-352 | Creative BioMart | 1 vial | 798.4 EUR |
|
Description: Protein |
|||
Bordetella bronchiseptica proteins (inactivated vaccine for dog) for ELISA |
|||
| BBV15-N-100 | Alpha Diagnostics | 100 ug | 343.2 EUR |
Anthrax vaccine |
|||
| VAC-0342 | Creative BioMart | 0.5ml | 1598.4 EUR |
|
Description: Protein |
|||
Typhoid Vaccine |
|||
| VAC-0356 | Creative BioMart | 0.5ml | 1598.4 EUR |
|
Description: Protein |
|||
Protein Kinase C, Panel, Western Blot Control (PKC) |
|||
| MBS652621-1Panel | MyBiosource | 1Panel | 850 EUR |
Protein Kinase C, Panel, Western Blot Control (PKC) |
|||
| MBS652621-5x1Panel | MyBiosource | 5x1Panel | 3600 EUR |
Rotavirus vaccine |
|||
| VAC-0352 | Creative BioMart | 0.5ml | 1598.4 EUR |
|
Description: Protein |
|||
Core Panel Multi-Tumor control slides, set of 5 |
|||
| TS900 | Innovex | Set of 5 | 145 EUR |
|
Description: Core Panel Multi-Tumor control slides, set of 5 |
|||
Core Panel Multi-Tumor control slides, set of 25 |
|||
| TS900-25 | Innovex | Set of 25 | 425 EUR |
|
Description: Core Panel Multi-Tumor control slides, set of 25 |
|||
Labcold Rigid Cool Block for Vaccine Transport Bag - EACH |
|||
| REF4122 | Scientific Laboratory Supplies | EACH | 22.37 EUR |
RUTI® Vaccine |
|||
| VAC-0353 | Creative BioMart | 0.5ml | 1598.4 EUR |
|
Description: Protein |
|||
Breast Panel Multi-Tumor control slides, set of 5 |
|||
| TS901 | Innovex | Set of 5 | 145 EUR |
|
Description: Breast Panel Multi-Tumor control slides, set of 5 |
|||
Breast Panel Multi-Tumor control slides, set of 25 |
|||
| TS901-25 | Innovex | Set of 25 | 395 EUR |
|
Description: Breast Panel Multi-Tumor control slides, set of 25 |
|||
Hepatitis A Vaccine |
|||
| SARS-401 | Creative BioMart | 1 vial | 798.4 EUR |
|
Description: Protein |
|||
Yellow Fever Vaccine |
|||
| VAC-0339 | Creative BioMart | 0.5ml | 1598.4 EUR |
|
Description: Protein |
|||
Vaccine adjuvant-1 |
|||
| HY-160198 | MedChemExpress | Get quote | Ask for price |
|
Description: Vaccine adjuvant-1 is an vaccine adjuvant is a vaccine adjuvant containing an oil phase, emulsifying agent and water[1]. |
|||
Recombinant flagellin FlicC vaccine adjuvant (TLR5 agonist); vaccine adjuvant |
|||
| AV-7010-50 | Alpha Diagnostics | 50 ug | 1074 EUR |
SARS-CoV-2 Spike RBD ELISA Kit (For Vaccine Development) |
|||
| RAS-A050 | ACROBIOSYSTEMS | 96tests | 631.3 EUR |
|
Description: The newly identified Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has posed a serious threat to human health. A rapid and effective assay kit detecting the levels of SARS-CoV-2 Spike Protein RBD is urgently needed to accelerate the development of COVID-19 vaccines. |
|||
Rabies virus Glycoprotein G ELISA Kit (For Vaccine Development) |
|||
| RAS-A167 | ACROBIOSYSTEMS | 96tests | 631.3 EUR |
|
Description: Rabies virus (RABV), scientific name Rabies lyssavirus, is a deadly neurotropic virus that causes rabies in humans and animals. Rabies virus has an extremely wide host range and its transmission most often occur through the saliva of animals. Without intervention prior to disease progression, rabies has the highest case fatality of any infectious disease. RABV contains a single-stranded negative-sense R genome that encodes five structural proteins: nucleoprotein (N), phosphoprotein (P), matrix protein (M), glycoprotein (G), and R-dependent R polymerase (L). Among these viral proteins, the RABV glycoprotein (RABV-G) is a pivotal player mediating virus entry and the major target of neutralizing antibodies, thus a key factor for vaccine and drug design.A rapid and effective assay kit detecting the levels ofRABV-G is urgently needed to accelerate the development of RABV vaccines. |
|||
Rubella Virus Vaccine |
|||
| VAC-0323 | Creative BioMart | 0.5ml | 1598.4 EUR |
|
Description: Protein |
|||
Control Animal Genomic DNA Panel, Set of any 5 species |
|||
| G-005 | Zyagen | 5X0.025mg | 720 EUR |
Control Animal Genomic DNA Panel, Set of any 10 species |
|||
| G-010 | Zyagen | 10x0.025mg | 1193 EUR |
Varicella Vaccine, Live |
|||
| VAC-0378 | Creative BioMart | 0.5ml | 1598.4 EUR |
Smallpox (Vaccinia) Vaccine, Live |
|||
| VLP-353 | Creative BioMart | 1 vial | 798.4 EUR |
|
Description: Protein |
|||
Recombinant BCG Vaccine |
|||
| PFC-338 | Creative BioMart | 1 vial | 798.4 EUR |
|
Description: Protein |
|||
Mycobacterium w. Vaccine |
|||
| COV2-370 | Creative BioMart | 1 vial | 798.4 EUR |
|
Description: Protein |
|||
Saponin Vaccine Adjuvant |
|||
| VAdv-Ly0009 | Creative Biolabs | 1 g | 1314 EUR |
|
Description: Saponin Vaccine Adjuvant, plant-based vaccine adjuvant. |
|||
SARS-CoV-2 Spike Protein ELISA Kit (For Vaccine Development) |
|||
| RAS-A039 | ACROBIOSYSTEMS | 96tests | 631.3 EUR |
|
Description: The newly identified Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has posed a serious threat to human health. A rapid and effective assay kit detecting the levels of SARS-CoV-2 Spike protein is urgently needed to accelerate the development of COVID-19 vaccines. |
|||
Rabbit Anti-West Nile Virus vaccine (WNV, Recombitek/DNA vaccine) antiserum |
|||
| WNV13-S | Alpha Diagnostics | 100 ul | 548.4 EUR |
Labcold Trolley for Use with 20L/30L Vaccine Transport Bags - EACH |
|||
| REF4118 | Scientific Laboratory Supplies | EACH | 286.42 EUR |
Vaccine adjuvant-1 (GMP) |
|||
| HY-160198G | MedChemExpress | Get quote | Ask for price |
|
Description: Vaccine adjuvant-1 GMP is Vaccine adjuvant-1 produced by using GMP guidelines. GMP small molecules works appropriately as an auxiliary reagent for cell therapy manufacture. Vaccine adjuvant-1 is an vaccine adjuvant is a vaccine adjuvant containing an oil phase, emulsifying agent and water[1]. |
|||
Moderna COVID-19 Vaccine |
|||
| H7N7-319 | Creative BioMart | 1 vial | 798.4 EUR |
|
Description: Protein |
|||
Customized Organic Acids Panel-2 in Urine Lyophilized Control Level 1 |
|||
| ZV-3066-02K1-20 | Zivak Technologies | 1 x 3mL | Ask for price |
SARS-CoV-2 Spike RBD (XBB.1.5) ELISA Kit (For Vaccine Development) |
|||
| RAS-A146 | ACROBIOSYSTEMS | 96tests | 845.3 EUR |
|
Description: The newly identified Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has posed a serious threat to human health. A rapid and effective assay kit detecting the levels of SARS-CoV-2 Spike RBD is urgently needed to accelerate the development of COVID-19 vaccines. |
|||
Peanut Oil vaccine adjuvant |
|||
| AV-5010-50 | Alpha Diagnostics | 50 ml | 270 EUR |
MUC1 Dendritic Cell Vaccine |
|||
| VAC-0369 | Creative BioMart | 0.5ml | 1598.4 EUR |
|
Description: Protein |
|||
Mineral Oil vaccine adjuvant |
|||
| AV-5020-50 | Alpha Diagnostics | 50 ml | 270 EUR |
SARS-CoV-2 Spike Trimer (XBB.1.5) ELISA Kit (For Vaccine Development) |
|||
| RAS-A145 | ACROBIOSYSTEMS | 96tests | 845.3 EUR |
|
Description: The newly identified Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has posed a serious threat to human health. A rapid and effective assay kit detecting the levels of SARS-CoV-2 Spike Trimer is urgently needed to accelerate the development of COVID-19 vaccines. |
|||
SARS-CoV-2 Spike Trimer (XBB.1) ELISA Kit (For Vaccine Development) |
|||
| RAS-A149 | ACROBIOSYSTEMS | 96tests | 845.3 EUR |
|
Description: The newly identified Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has posed a serious threat to human health. A rapid and effective assay kit detecting the levels of SARS-CoV-2 Spike Trimer is urgently needed to accelerate the development of COVID-19 vaccines. |
|||
Dengue tetravalent vaccine, live |
|||
| VZV-421 | Creative BioMart | 1 vial | 798.4 EUR |
|
Description: Protein |
|||
HS15 Kolliphore vaccine adjuvant |
|||
| AV-6010-100 | Alpha Diagnostics | 100 g | 343.2 EUR |
Recombinant Hepatitis B Vaccine |
|||
| NG2-351 | Creative BioMart | 1 vial | 798.4 EUR |
|
Description: Protein |
|||
Pam2CSK4 vaccine adjuvant; Biotin conjugate |
|||
| AV-9020-B | Alpha Diagnostics | 1 mg | 489.6 EUR |
Pam2CSK4 vaccine adjuvant; Biotin conjugate |
|||
| AV-9020-B-100 | Alpha Diagnostics | 100 ug | 196.8 EUR |
Typhoid Vi polysaccharide vaccine |
|||
| VAC-0357 | Creative BioMart | 0.5ml | 1598.4 EUR |
|
Description: Protein |
|||
Calcium phosphate vaccine adjuvant |
|||
| AV-1020-100 | Alpha Diagnostics | 100 ml | 262.8 EUR |
Mannide monooleate vaccine adjuvant |
|||
| AV-5030-5 | Alpha Diagnostics | 5 g | 196.8 EUR |
Pam2CSK4 vaccine adjuvant, unlabeled |
|||
| AV-9020-1 | Alpha Diagnostics | 1 mg | 489.6 EUR |
Pam3CSK4 vaccine adjuvant, unlabeled |
|||
| AV-9025-1 | Alpha Diagnostics | 1 mg | 343.2 EUR |
Recombinant Varicella Zoster Vaccine |
|||
| VAC-0270 | Creative BioMart | 0.5ml | 1598.4 EUR |
|
Description: Protein |
|||
SARS-CoV-2 Spike S1 (B.1.1.529) Specific ELISA Kit (For Vaccine Development) |
|||
| RAS-A170 | ACROBIOSYSTEMS | 96tests | 845.3 EUR |
|
Description: The newly identified Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has posed a serious threat to human health. A rapid and effective assay kit detecting the levels of SARS-CoV-2 Spike S1 is urgently needed to accelerate the development of COVID-19 vaccines. |
|||
BNT162c2 SARS-CoV-2 Vaccine |
|||
| INB-326 | Creative BioMart | 1 vial | 798.4 EUR |
|
Description: Protein |
|||
Adenovirus type 7 vaccine live |
|||
| MPC-341 | Creative BioMart | 1 vial | 798.4 EUR |
|
Description: Protein |
|||
BNT162a1 SARS-CoV-2 Vaccine |
|||
| THP-0325 | Creative BioMart | 1 vial | 2398.4 EUR |
|
Description: Protein |
|||
BNT162b1 SARS-CoV-2 Vaccine |
|||
| VAC-0325 | Creative BioMart | 0.5ml | 1598.4 EUR |
|
Description: Protein |
|||
SARS-CoV-2 Spike RBD (B.1.1.529) Specific ELISA Kit (For Vaccine Development) |
|||
| RAS-A082 | ACROBIOSYSTEMS | 96tests | 845.3 EUR |
|
Description: The newly identified Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has posed a serious threat to human health. A rapid and effective assay kit detecting the levels of SARS-CoV-2 Spike protein is urgently needed to accelerate the development of COVID-19 vaccines. |
|||
SARS-CoV-2 Spike RBD (B.1.617.2) Specific ELISA Kit (For Vaccine Development) |
|||
| RAS-A092 | ACROBIOSYSTEMS | 96tests | 845.3 EUR |
|
Description: The newly identified Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has posed a serious threat to human health. A rapid and effective assay kit detecting the levels of SARS-CoV-2 Spike protein is urgently needed to accelerate the development of COVID-19 vaccines. |
|||
Recombinant Ad26.COV2.S vaccine |
|||
| MPP-340 | Creative BioMart | 1 vial | 798.4 EUR |
|
Description: Protein |
|||
RWJ 21757 Synthetic vaccine adjuvant |
|||
| AV-9010-1 | Alpha Diagnostics | 1 mg | 196.8 EUR |
RWJ 21757 Synthetic vaccine adjuvant |
|||
| AV-9010-5 | Alpha Diagnostics | 5 mg | 343.2 EUR |
Standard Nutrient Broth (H.S. Vaccine |
|||
| M116-500G | EWC Diagnostics | 1 unit | 24.58 EUR |
|
Description: Standard Nutrient Broth (H.S. Vaccine |
|||
Inactivated SARS-Cov-2 Vaccine |
|||
| VAC-0328 | Creative BioMart | 0.5ml | 1598.4 EUR |
|
Description: Protein |
|||
SARS-CoV-2 Spike Trimer (B.1.617.2) Specific ELISA Kit (For Vaccine Development) |
|||
| RAS-A055 | ACROBIOSYSTEMS | 96tests | 845.3 EUR |
|
Description: The newly identified Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has posed a serious threat to human health. A rapid and effective assay kit detecting the levels of SARS-CoV-2 Spike protein is urgently needed to accelerate the development of COVID-19 vaccines. |
|||
SARS-CoV-2 Spike Trimer (B.1.1.529) Specific ELISA Kit (For Vaccine Development) |
|||
| RAS-A081 | ACROBIOSYSTEMS | 96tests | 845.3 EUR |
|
Description: The newly identified Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has posed a serious threat to human health. A rapid and effective assay kit detecting the levels of SARS-CoV-2 Spike protein is urgently needed to accelerate the development of COVID-19 vaccines. |
|||
SARS-CoV-2 Spike Trimer (BA.4) Specific ELISA Kit (For Vaccine Development) |
|||
| RAS-A124 | ACROBIOSYSTEMS | 96tests | 845.3 EUR |
|
Description: The newly identified Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has posed a serious threat to human health. A rapid and effective assay kit detecting the levels of SARS-CoV-2 Spike protein is urgently needed to accelerate the development of COVID-19 vaccines. |
|||
SARS-CoV-2 Spike Trimer (BA.5) Specific ELISA Kit (For Vaccine Development) |
|||
| RAS-A125 | ACROBIOSYSTEMS | 96tests | 845.3 EUR |
|
Description: The newly identified Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has posed a serious threat to human health. A rapid and effective assay kit detecting the levels of SARS-CoV-2 Spike protein is urgently needed to accelerate the development of COVID-19 vaccines. |
|||
Varicella Zoster Virus Glycoprotein E (VZV gE) ELISA Kit (For Vaccine Development) |
|||
| RAS-A135 | ACROBIOSYSTEMS | 96tests | 631.3 EUR |
|
Description: Varicella-zoster virus (VZV) the etiologic agent of chickenpox and herpes zoster [HZ], is highly contagious and still endemic worldwide. Glycoprotein E (gE) is one of the known glycoproteins (gB, gC, gE, gH, gI, gK, gI) of VZV that is most abundantly expressed on the surface of virus and infected cells, playing an important role in viral replication and cell-to-cell spread. The strongly immunogenic gE can provide strong IgG signal in body fluid, which makes it ideal to be developed as an antigen for analysis of Immunogenicity in the development of VZV vaccine.Therefore,It's helpful to develop the Varicella Zoster Virus Glycoprotein E (VZV gE) ELISA Kit to quantitative detection the VZV gE antigen in vaccine samples during the manufacture and quality control of vaccine development. |
|||
HRSV (A) Pre-Fusion glycoprotein F0 Specific ELISA Kit (For Vaccine Development) |
|||
| RAS-A163 | ACROBIOSYSTEMS | 96tests | 845.3 EUR |
|
Description: Respiratory syncytial virus (RSV) is a highly contagious virus causing severe infection in infants and the elderly. Various approaches are being used to develop an effective RSV vaccine. The RSV fusion (F) subunit, particularly the cleaved trimeric pre-fusion F, is one of the most promising vaccine candidates under development.A rapid and effective assay kit detecting the levels of HRSV (A) Pre-Fusion glycoprotein F0 is urgently needed to accelerate the development of RSV vaccines. |
|||
HRSV (A) Post-Fusion glycoprotein F0 Specific ELISA Kit (For Vaccine Development) |
|||
| RAS-A169 | ACROBIOSYSTEMS | 96tests | 845.3 EUR |
|
Description: Most in vitro RSV neutralizing antibodies in human sera are directed against the prefusion conformation, but due to its instability the prefusion conformation has a propensity to prematurely refold into the stable postfusion conformation, both in solution and on the surface of the virions. An RSV F protein that has both high expression levels and maintains a stable prefusion conformation would, therefore, be a promising subunit vaccine candidate against RSV. To facilitate the RSV-related research, drug trials and vaccine development,a rapid and effective assay kit detecting the specific levels of HRSV (A) Post-Fusion glycoprotein F0 is urgently needed to accelerate the development of RSV vaccines. |
|||
Ebola Zaire vaccine (live, attenuated) |
|||
| VZV-422 | Creative BioMart | 1 vial | 798.4 EUR |
|
Description: Protein |
|||
SARS-CoV-2 Spike RBD (Wild Type) Specific ELISA Kit (For Vaccine Development) |
|||
| RAS-A116 | ACROBIOSYSTEMS | 96tests | 845.3 EUR |
|
Description: The newly identified Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has posed a serious threat to human health. A rapid and effective assay kit detecting the levels of SARS-CoV-2 Spike protein is urgently needed to accelerate the development of COVID-19 vaccines. |
|||
Pfizer-BioNTech Covid-19 Vaccine |
|||
| VAC-0376 | Creative BioMart | 0.5ml | 1598.4 EUR |
|
Description: Protein |
|||
Mouse Anti-Her2 Protein (ECD) ELISA kit for Her2 vaccine, 96 tests, Quantitative |
|||
| 200-620-HRH | Alpha Diagnostics | 1 Kit | 927.6 EUR |
Measles virus vaccine live attenuated |
|||
| VAC-0366 | Creative BioMart | 0.5ml | 1598.4 EUR |
|
Description: Protein |
|||
SARS-CoV-2 Spike Trimer (Wild Type) Specific ELISA Kit (For Vaccine Development) |
|||
| RAS-A115 | ACROBIOSYSTEMS | 96tests | 845.3 EUR |
|
Description: The newly identified Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has posed a serious threat to human health. A rapid and effective assay kit detecting the levels of SARS-CoV-2 Spike protein is urgently needed to accelerate the development of COVID-19 vaccines. |
|||
Pam3CSK4 vaccine adjuvant; FITC labelled |
|||
| AV-9025-F | Alpha Diagnostics | 100 ug | 416.4 EUR |
Pertussis Toxin B.Pertussis, vaccine grade |
|||
| AV-9130-50 | Alpha Diagnostics | 50 ug | 634.8 EUR |
Subunit Influenza virus Vaccine Antigen |
|||
| H1N1-323 | Creative BioMart | 1 vial | 798.4 EUR |
|
Description: Protein |
|||
Recombinant Trimeric S Subunit Vaccine |
|||
| HIV-291 | Creative BioMart | 1 vial | 798.4 EUR |
|
Description: Protein |
|||
Subunit Influenza virus Vaccine Antigen |
|||
| VAC-0322 | Creative BioMart | 0.5ml | 1598.4 EUR |
|
Description: Protein |
|||
Peptidoglycan (S. aureus); vaccine adjuvant |
|||
| AV-7045-25 | Alpha Diagnostics | 25 mg | 1220.4 EUR |
Peptidoglycan (S. aureus); vaccine adjuvant |
|||
| AV-7045-5 | Alpha Diagnostics | 5 mg | 343.2 EUR |
Hepatitis B Vaccine Antigen (Recombinant) |
|||
| THP-0194 | Creative BioMart | 20ug | 318.4 EUR |
|
Description: Protein |
|||
Varicella Zoster Vaccine (Live/attenuated) |
|||
| VAC-0358 | Creative BioMart | 0.5ml | 1598.4 EUR |
|
Description: Protein |
|||
Zika Virus (ZIKV) Envelop protein ELISA kit for vaccine testing, 48 tests, Quantitative |
|||
| RV-403001-ENV-48 | Alpha Diagnostics | 1 Kit | 1000.8 EUR |
Pam3CSK4 vaccine adjuvant; Biotin labelled |
|||
| AV-9025-B | Alpha Diagnostics | 100 ug | 416.4 EUR |
SARS-CoV-2 Spike RBD (BA.4 & BA.5) Specific ELISA Kit (For Vaccine Development) |
|||
| RAS-A126 | ACROBIOSYSTEMS | 96tests | 845.3 EUR |
|
Description: The newly identified Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has posed a serious threat to human health. A rapid and effective assay kit detecting the levels of SARS-CoV-2 Spike protein is urgently needed to accelerate the development of COVID-19 vaccines. |
|||
Custom Testing of Samples for Antibodies (IgA/IgG/IgM) to West Nile Virus vaccines (WNV-ENV/NS1/prM) vaccine by ELISA |
|||
| 910-360-CUX | Alpha Diagnostics | Custom | Ask for price |
NATtrol Respiratory Panel 2 (RP2) Controls (Ea) |
|||
| NATRPC2-BIO | Zeptometrix | Ea | 550.46 EUR |
|
Description: Please contact Gentaur in order to receive the datasheet of the product. |
|||
Human Anti-Her2 Protein (ECD) IgG ELISA kit for Her2 vaccine, 96 tests, Quantitative |
|||
| 200-600-HRH | Alpha Diagnostics | 1 Kit | 927.6 EUR |
Human Anti-Her2 Protein (ECD) IgM ELISA kit for Her2 vaccine, 96 tests, Quantitative |
|||
| 200-610-HRM | Alpha Diagnostics | 1 Kit | 927.6 EUR |
Mouse Anti-Her2 Protein (ECD) IgM ELISA kit for Her2 vaccine, 96 tests, Quantitative |
|||
| 200-630-HRM | Alpha Diagnostics | 1 Kit | 927.6 EUR |
Labcold Vaccine Transport Bag 3L - EACH |
|||
| REF4110 | Scientific Laboratory Supplies | EACH | 189 EUR |
Vaccinia virus Complement control protein C3 (VACWR025) |
|||
| 1-CSB-YP302389VAI | Cusabio |
|
|
|
Description: Recombinant Vaccinia virus Complement control protein C3(VACWR025) expressed in Yeast |
|||
Labcold Vaccine Transport Bag 10L - EACH |
|||
| REF4112 | Scientific Laboratory Supplies | EACH | 249.75 EUR |
Labcold Vaccine Transport Bag 20L - EACH |
|||
| REF4114 | Scientific Laboratory Supplies | EACH | 310.5 EUR |
Labcold Vaccine Transport Bag 30L - EACH |
|||
| REF4116 | Scientific Laboratory Supplies | EACH | 429.3 EUR |
Thiomersal (Thimerosal) ExiPlus, Multi-Compendial (Suitable for Vaccine&Diagnostic Production), 98% |
|||
| 27662 | Sisco Laboratories | 10 Gms | 67.5 EUR |
|
Description: Part B |
|||
Human Anti-Human Chorionic Gonadotropin (HCG) IgG ELISA kit for HCG Vaccine, 96 tests |
|||
| 500-300-HHG | Alpha Diagnostics | 1 kit | 854.4 EUR |
Mouse Anti-Human Chorionic Gonadotropin (HCG) IgG ELISA kit for HCG Vaccine, 96 tests |
|||
| 500-330-HRG | Alpha Diagnostics | 1 kit | 854.4 EUR |
B.Q. Vaccine HiCynth™ Medium (Thioglycol |
|||
| MCD462-500G | EWC Diagnostics | 1 unit | 35.17 EUR |
|
Description: B.Q. Vaccine HiCynth™ Medium (Thioglycol |
|||
Varicella Zoster Vaccine Antigen (Recombinant) |
|||
| THP-0210 | Creative BioMart | 50ug | 1038.4 EUR |
|
Description: Protein |
|||
Meningococcal polysaccharide Group A Vaccine |
|||
| H3N2-317 | Creative BioMart | 0.845mg | 798.4 EUR |
|
Description: Protein |
|||
Meningococcal polysaccharide Group C Vaccine |
|||
| VAC-0317 | Creative BioMart | 1mg | 1598.4 EUR |
|
Description: Protein |
|||
Meningococcal polysaccharide Group Y Vaccine |
|||
| VAC-0318 | Creative BioMart | 0.958mg | 1598.4 EUR |
|
Description: Protein |
|||
Rabbit Anti-Human Chorionic Gonadotropin (HCG) IgG ELISA kit for HCG Vaccine, 96 tests |
|||
| 500-320-HMG | Alpha Diagnostics | 1 kit | 854.4 EUR |
Zika Virus NS1 (ZIKV-NS1) protein ELISA kit for vaccine testing, 96 tests, Quantitative |
|||
| RV-403301-NS1-48 | Alpha Diagnostics | 1 Kit | 1000.8 EUR |
Standard Nutrient Broth (H.S. Vaccine Medium) |
|||
| 68818 | Sisco Laboratories | 100 Gms | 6.84 EUR |
|
Description: Part D |
|||
Standard Nutrient Broth (H.S. Vaccine Medium) |
|||
| 68818-1 | Sisco Laboratories | 500 Gms | 20.53 EUR |
|
Description: Part D |
|||
HER2 peptide, (369 ?377), E75 vaccine candidate |
|||
| HER2-369-P | Alpha Diagnostics | 5 mg | 416.4 EUR |
HER2 peptide, (654 ? 662), GP2 vaccine candidate |
|||
| HER2-654-P | Alpha Diagnostics | 5 mg | 416.4 EUR |
Purified Cholera Toxin protein; vaccine grade |
|||
| AV-9135-1000 | Alpha Diagnostics | 1 mg | 781.2 EUR |
Purified Cholera Toxin protein; vaccine grade |
|||
| AV-9135-500 | Alpha Diagnostics | 500 ug | 416.4 EUR |
Influenza A, H1N1, Reassortant Vaccine Strain |
|||
| MBS655221-1mL | MyBiosource | 1mL | 505 EUR |
Influenza A, H1N1, Reassortant Vaccine Strain |
|||
| MBS655221-5x1mL | MyBiosource | 5x1mL | 2050 EUR |
Recombinant Vaccinia virus Complement control protein (C3L) |
|||
| MBS1024068-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | 1125 EUR |
Recombinant Vaccinia virus Complement control protein (C3L) |
|||
| MBS1024068-002mgEColi | MyBiosource | 0.02mg(E-Coli) | 750 EUR |
Recombinant Vaccinia virus Complement control protein (C3L) |
|||
| MBS1024068-002mgYeast | MyBiosource | 0.02mg(Yeast) | 420 EUR |
Recombinant Vaccinia virus Complement control protein (C3L) |
|||
| MBS1024068-01mgEColi | MyBiosource | 0.1mg(E-Coli) | 900 EUR |
Recombinant Vaccinia virus Complement control protein (C3L) |
|||
| MBS1024068-01mgYeast | MyBiosource | 0.1mg(Yeast) | 695 EUR |
Recombinant Vaccinia virus Complement control protein (C3L) |
|||
| MBS1091647-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | 1125 EUR |
Recombinant Vaccinia virus Complement control protein (C3L) |
|||
| MBS1091647-002mgEColi | MyBiosource | 0.02mg(E-Coli) | 755 EUR |
Recombinant Vaccinia virus Complement control protein (C3L) |
|||
| MBS1091647-002mgYeast | MyBiosource | 0.02mg(Yeast) | 915 EUR |
Recombinant Vaccinia virus Complement control protein (C3L) |
|||
| MBS1091647-01mgEColi | MyBiosource | 0.1mg(E-Coli) | 905 EUR |
Recombinant Vaccinia virus Complement control protein (C3L) |
|||
| MBS1091647-01mgYeast | MyBiosource | 0.1mg(Yeast) | 1070 EUR |
Marek's Disease Vaccine, Live Polyclonal Antibody |
|||
| MBS9233795-01mL | MyBiosource | 0.1mL | 415 EUR |
Marek's Disease Vaccine, Live Polyclonal Antibody |
|||
| MBS9233795-5x01mL | MyBiosource | 5x0.1mL | 1841 EUR |
Recombinant Vaccinia virus omplement control protein C3 (C3L) |
|||
| MBS9423772-002mg | MyBiosource | 0.02mg | 505 EUR |
Recombinant Vaccinia virus omplement control protein C3 (C3L) |
|||
| MBS9423772-01mg | MyBiosource | 0.1mg | 895 EUR |
Recombinant Vaccinia virus omplement control protein C3 (C3L) |
|||
| MBS9423772-1mg | MyBiosource | 1mg | 2990 EUR |
Recombinant Vaccinia virus omplement control protein C3 (C3L) |
|||
| MBS9423772-5x1mg | MyBiosource | 5x1mg | 13315 EUR |
NATtrol Respiratory Panel 2.1 (RP2.1) Controls (12 x 0.3mL) |
|||
| NATRPC2.1-BIO | Zeptometrix | 12 x 0.3mL | 529 EUR |
Vet-SAP Vaccine adjuvant, (EU GMP grade) >95%; |
|||
| AV-4020-100 | Alpha Diagnostics | 100 mg | 196.8 EUR |
Vet-SAP Vaccine adjuvant, (EU GMP grade) >95%; |
|||
| AV-4020-1000 | Alpha Diagnostics | 1 g | 634.8 EUR |
VacciGel Direct ELISA for the measurement of Hepatitis B Vaccine (HBsAg) formulated in Alum, 48 tests, Quantitative |
|||
| VAC-HBS-50 | Alpha Diagnostics | 1 Kit | 927.6 EUR |
Vaccinia Virus B18R/B19R Insect Cell Lysate (WB positive control) |
|||
| MBS8115778-03mg | MyBiosource | 0.3mg | 280 EUR |
Vaccinia Virus B18R/B19R Insect Cell Lysate (WB positive control) |
|||
| MBS8115778-5x03mg | MyBiosource | 5x0.3mg | 1205 EUR |
ID-VAC VacciGel Direct ELISA for the identification of Hepatitis B Vaccine (HBsAg) formulated in Alum, 24 tests |
|||
| VAC-HBS-VID-24 | Alpha Diagnostics | 1 Kit | 634.8 EUR |
ID-VAC VacciGel Direct ELISA for the identification of Tetanus Toxoid Vaccine (TTX) formulated in Alum, 24 tests |
|||
| VAC-TTX-VID-24 | Alpha Diagnostics | 1 Kit | 634.8 EUR |
Meningococcal polysaccharide Group W-135 Vaccine |
|||
| H5N1-318 | Creative BioMart | 1mg | 798.4 EUR |
|
Description: Protein |
|||
Influenza Vaccine Antigen(Split Virion), Inactivated |
|||
| VAC-0361 | Creative BioMart | 0.5ml | 1598.4 EUR |
|
Description: Protein |
|||
Recombinant Vaccinia virus Complement control protein C3 (VACWR025) |
|||
| CSB-YP302389VAI | Cusabio | 6104 mg | Ask for price |
Recombinant Vaccinia virus Complement control protein C3(VACWR025) |
|||
| AP74192 | SAB | 1mg | 3389 EUR |
Complete Freund?s Adjuvant (CFA);vaccine adjuvant |
|||
| AV-3010-10 | Alpha Diagnostics | 10 ml | 343.2 EUR |
Complete Freund?s Adjuvant (CFA);vaccine adjuvant |
|||
| AV-3010-100 | Alpha Diagnostics | 10x10 ml | 489.6 EUR |
Recombinant Human Glutamic Acid Decarboxylase Vaccine |
|||
| VAC-0290 | Creative BioMart | 0.5ml | 1598.4 EUR |
|
Description: Protein |
|||
ID-VAC VacciGel Direct ELISA for the identification of Diphtheria Toxoid Vaccine (DTX) formulated in Alum, 24 tests |
|||
| VAC-DTX-VID-24 | Alpha Diagnostics | 1 Kit | 634.8 EUR |
Recombinant CDV H Protein (aa 1-607) (strain Convac vaccine) |
|||
| VAng-Lsx04670-inquire | Creative Biolabs | inquire | Ask for price |
|
Description: Canine distemper virus (strain Convac vaccine) Hemagglutinin glycoprotein, recombinant protein. |
|||
NATtrol Flu Verification Panel (7 X 0.5 mL) |
|||
| NATFVP-NNS | Zeptometrix | 7 X 0.5 mL | 417 EUR |
HER2 multi peptide, (776-790,927-941,1116-1180); vaccine candidate |
|||
| HER2-MP2 | Alpha Diagnostics | 5 mg | 781.2 EUR |
HER2 multi peptide, (42-56,98-114,328-345); vaccine candidate |
|||
| HER2-MP3 | Alpha Diagnostics | 5 mg | 634.8 EUR |
Incomplete Freund?s Adjuvant (IFA);vaccine adjuvant |
|||
| AV-3015-10 | Alpha Diagnostics | 10 ml | 343.2 EUR |
Incomplete Freund?s Adjuvant (IFA);vaccine adjuvant |
|||
| AV-3015-100 | Alpha Diagnostics | 10x10 ml | 489.6 EUR |
Labcold 543L Pharmacy and Vaccine Refrigerator - EACH |
|||
| RLDF1819 | Scientific Laboratory Supplies | EACH | 5201.55 EUR |
Yellow Fever Vaccine Serum: 12-Month (IgG) Bleed |
|||
| SER71209-1000 | The Native Antigen Company | 1ml | 542.2 EUR |
Yellow Fever Vaccine Serum: 12-Month (IgG) Bleed |
|||
| SER71209-500 | The Native Antigen Company | 0.5ml | 354.66 EUR |
Rabbit Anti-Bordetella bronchiseptica vaccine antiserum |
|||
| BBV11-S | Alpha Diagnostics | 100 ug | 562.8 EUR |
In vitro cross-resistance to doravirine in a panel of HIV-1 clones harbouring a number of NNRTI resistance mutations
Targets: Doravirine is a not too long ago licensed HIV-1 NNRTI with improved efficacy, pharmacokinetics and security profile in contrast with efavirenz and restricted cross-resistance with rilpivirine and etravirine. On this in vitro research, cross-resistance to doravirine was analysed in a consultant panel of NNRTI-resistant clones.
Strategies: In vitro phenotypic susceptibility to doravirine was assessed in 10 clinically derived infectious clones with intermediate- to high-level resistance to rilpivirine, etravirine, efavirenz and nevirapine, and in NL4-Three site-directed mutants harbouring Ok103N, Y181C, M230L or Ok103N/Y181C NNRTI mutations
Outcomes: Though not one of the infectious clones harboured any of the most important doravirine resistance-associated mutations (RAMs) included within the IAS-USA reference listing, doravirine fold change (FC) values have been corresponding to or larger than these calculated for different NNRTIs, significantly etravirine and rilpivirine.
As anticipated, single NNRTI mutations Ok103N and Y181C didn’t impair doravirine susceptibility (FC 1.Four and 1.8, respectively), whereas decreased exercise was noticed with the only M230L or double Ok103N/Y181C mutations (FC 7.6 and 4.9, respectively). Median FC values elevated considerably with growing numbers of NNRTI RAMs (P = 0.005) and have been >10 in 4/Four and 1/Four clones harbouring 4 and three NNRTI RAMs, respectively. FC values correlated nicely with predicted susceptibility as inferred by Stanford HIV Drug Resistance Database (HIVdb) and ANRS algorithms (each P < 0.001).
Conclusions: Substantial cross-resistance to doravirine was detected in NNRTI-resistant viruses harbouring complicated mutational patterns, even within the absence of main IAS-USA doravirine RAMs. Due to this fact, primarily based on the straightforward IAS-USA reference listing, doravirine resistance could also be underestimated in viruses harbouring a number of NNRTI mutations.
Affiliation between modifications in financial exercise and catastrophic well being expenditure: findings from the Korea Well being Panel Survey, 2014-2016
Background: The speed of catastrophic well being expenditure (CHE) continues to rise in South Korea. This research examined the affiliation between modifications in financial exercise and CHE experiences in South Korea.
Strategies: This research analyzed the Korea Well being Panel Survey information utilizing a logistic regression evaluation to check the affiliation between modifications in financial exercise in 2014-2015 and the members’ CHE experiences in 2015. The research included a complete of 12,454 people over the age of 19. The subgroup analyses have been organized by intercourse, age, health-related variables, and family degree variables, and the explanations for leaving financial exercise.
Outcomes: Those that stop financial actions have been extra more likely to expertise CHE than those that continued to have interaction in financial actions (OR [odds ratio] = 2.10; 95% CI [confidence interval]: 1.31-3.36). The subgroup evaluation outcomes, in accordance with health-related variables, confirmed that there’s a tendency to the next Charlson comorbidity index, the next OR, and, in teams that stop their financial actions, folks with disabilities have been extra more likely to expertise CHE than folks with out disabilities (OR = 5.63; 95% CI 1.71-18.59, OR = 1.82; 95% CI 1.08-3.08, respectively).
One other subgroup evaluation discovered that if the explanation for not taking part in financial exercise was a health-related concern, the participant was extra more likely to expertise CHE (energetic → inactive: OR = 2.40; 95% CI 0.61-9.43, inactive → inactive OR = 1.65; 95% CI 1.01-2.68).
Conclusions: These people who turned unemployed have been extra more likely to expertise CHE, particularly if well being issues precipitated the job loss. Due to this fact, efforts are wanted to develop protection for these individuals who undergo from excessive medical bills.
SeroDetect HIV-Ab Verification Panel (5 X 1.5 mL) |
|||
| KZMC006 | Zeptometrix | 5 X 1.5 mL | 286 EUR |
SeroDetect Anti-HBs Verification Panel (6 X 1.5 mL) |
|||
| KZMC008 | Zeptometrix | 6 X 1.5 mL | 286 EUR |
SeroDetect Anti-HCV Verification Panel (5 X 1.5 mL) |
|||
| KZMC010 | Zeptometrix | 5 X 1.5 mL | 286 EUR |
SeroDetect Dengue Fever Verification Panel (9 X 0.5 mL) |
|||
| KZMC028 | Zeptometrix | 10 X 0.5 mL | 277 EUR |
SeroDetect Anti-HBcore Verification Panel (5 X 1.5 mL) |
|||
| KZMC009 | Zeptometrix | 5 X 1.5 mL | 334.56 EUR |
|
Description: Please contact Gentaur in order to receive the datasheet of the product. |
|||
SeroDetect HIV-Ab Range Verification Panel (10 X 1.5 mL) |
|||
| KZMC024 | Zeptometrix | 10 X 1.5 mL | 286 EUR |
SeroDetect West Nile Virus Verification Panel (10 X 0.5 mL) |
|||
| KZMC027 | Zeptometrix | 10 X 0.5 mL | 334.56 EUR |
|
Description: Please contact Gentaur in order to receive the datasheet of the product. |
|||
SeroDetect HCV-Ab Mixed Titer Verification Panel I (15 X 0.25 mL) |
|||
| KZMC022 | Zeptometrix | 15 X 0.25 mL | 269 EUR |
SeroDetect HIV-1/ HIV-2 Ag/Ab Combo Verification Panel (5 X 1.25mL) |
|||
| KZMC030 | Zeptometrix | 5 X 1.25mL | 328 EUR |
Recombinant purified Hepatitis Surface Antigen (HBsAg) protein control for WB |
|||
| HBA11-C | Alpha Diagnostics | 100 ul | 343.2 EUR |
Protein Kinase C, Panel, Western Blot Control (PKC) |
|||
| MBS652621-1Panel | MyBiosource | 1Panel | 850 EUR |
Protein Kinase C, Panel, Western Blot Control (PKC) |
|||
| MBS652621-5x1Panel | MyBiosource | 5x1Panel | 3600 EUR |
Core Panel Multi-Tumor control slides, set of 5 |
|||
| TS900 | Innovex | Set of 5 | 145 EUR |
|
Description: Core Panel Multi-Tumor control slides, set of 5 |
|||
Core Panel Multi-Tumor control slides, set of 25 |
|||
| TS900-25 | Innovex | Set of 25 | 425 EUR |
|
Description: Core Panel Multi-Tumor control slides, set of 25 |
|||
Breast Panel Multi-Tumor control slides, set of 5 |
|||
| TS901 | Innovex | Set of 5 | 145 EUR |
|
Description: Breast Panel Multi-Tumor control slides, set of 5 |
|||
Breast Panel Multi-Tumor control slides, set of 25 |
|||
| TS901-25 | Innovex | Set of 25 | 395 EUR |
|
Description: Breast Panel Multi-Tumor control slides, set of 25 |
|||
Control Animal Genomic DNA Panel, Set of any 5 species |
|||
| G-005 | Zyagen | 5X0.025mg | 720 EUR |
Control Animal Genomic DNA Panel, Set of any 10 species |
|||
| G-010 | Zyagen | 10x0.025mg | 1193 EUR |
Hepatitis B Surface Antigen (HBsAg) pre-S1 peptide control/blocking peptide |
|||
| HBVS12-P | Alpha Diagnostics | 100 ug | 270 EUR |
Customized Organic Acids Panel-2 in Urine Lyophilized Control Level 1 |
|||
| ZV-3066-02K1-20 | Zivak Technologies | 1 x 3mL | Ask for price |
Hepatitis B Surface Antigen (HBsAg) pre-S2 (55-aa) control/blocking peptide |
|||
| HBVS23-P | Alpha Diagnostics | 100 ug | 270 EUR |
NATtrol Respiratory Panel 2 (RP2) Controls (Ea) |
|||
| NATRPC2-BIO | Zeptometrix | Ea | 550.46 EUR |
|
Description: Please contact Gentaur in order to receive the datasheet of the product. |
|||
NATtrol Respiratory Panel 2.1 (RP2.1) Controls (12 x 0.3mL) |
|||
| NATRPC2.1-BIO | Zeptometrix | 12 x 0.3mL | 529 EUR |
White light panel for UltraSlim LED illuminator |
|||
| SW-04 | MaestroGen | each | 70 EUR |
|
Description: White light for protein gel illumination, Coomassie blue stained or silver stained media. |
|||
CleanPlex for MGI SARS-CoV-2 Panel (384) |
|||
| 918003 | BioServUK | 384 reactions | 21034 EUR |
|
Description: CleanPlex for MGI SARS-CoV-2 Panel (384) |
|||
Eppendorf Centrifuge 5430R Knob Control Refrigerated- IVD Only - EACH |
|||
| E5428000465 | Scientific Laboratory Supplies | EACH | 9130.05 EUR |
HBsAg |
|||
| ant-194 | ProSpec Tany | 2µg | 60 EUR |
|
Description: Recombinant Anti Hepatitis B Virus Surface Antigen Ck |
|||
HBsAg |
|||
| ant-773 | ProSpec Tany | 100µg | 200 EUR |
|
Description: Mouse Anti Hepatitis B Surface Antigen |
|||
HBsAg |
|||
| MBS8564572-01mLAF405L | MyBiosource | 0.1mL(AF405L) | 565 EUR |
HBsAg |
|||
| MBS8564572-01mLAF405S | MyBiosource | 0.1mL(AF405S) | 565 EUR |
HBsAg |
|||
| MBS8564572-01mLAF610 | MyBiosource | 0.1mL(AF610) | 565 EUR |
HBsAg |
|||
| MBS8564572-01mLAF635 | MyBiosource | 0.1mL(AF635) | 565 EUR |
HBsAg |
|||
| MBS8564572-02mL | MyBiosource | 0.2mL | 345 EUR |
HBsAg |
|||
| MBS344145-5x7mLRTU | MyBiosource | 5x7mL(RTU) | 755 EUR |
HBsAg |
|||
| MBS344145-7mLRTU | MyBiosource | 7mL(RTU) | 220 EUR |
ELISA kit for Human HBsAg (Hepatitis B surface antigen) |
|||
| E-EL-H1567 | Elabscience Biotech | 1 plate of 96 wells | 640.8 EUR |
|
Description: A sandwich ELISA kit for quantitative measurement of Human HBsAg (Hepatitis B surface antigen) in samples from Serum, Plasma, Cell supernatant |
|||
CleanPlex for MGI SARS-CoV-2 Panel (8) |
|||
| 918001 | BioServUK | 8 reactions | 647 EUR |
|
Description: CleanPlex for MGI SARS-CoV-2 Panel (8) |
|||
CleanPlex for MGI SARS-CoV-2 Panel (96) |
|||
| 918002 | BioServUK | 96 reactions | 5522 EUR |
|
Description: CleanPlex for MGI SARS-CoV-2 Panel (96) |
|||
HbsAg (Ag) |
|||
| V1060 | Antagene | 0.2mg | 180 EUR |
HBsAg (ayw) |
|||
| GWB-396DAC | GenWay Biotech | 0.5 mg | Ask for price |
HBsAg ayw |
|||
| hbs-870 | ProSpec Tany | 10µg | 60 EUR |
|
Description: Recombinant Hepatitis B Surface Antigen ayw subtype, Saccharomyces |
|||
HBsAg adw |
|||
| hbs-872 | ProSpec Tany | 20µg | 60 EUR |
|
Description: Recombinant Hepatitis B Surface Antigen Adw subtype |
|||
HBsAg ayw |
|||
| hbs-877 | ProSpec Tany | 10µg | 60 EUR |
|
Description: Recombinant Hepatitis B Surface Antigen ayw subtype |
|||
HBsAg (adr) |
|||
| GWB-86C861 | GenWay Biotech | 0.5 mg | Ask for price |
HBsAg (adw) |
|||
| GWB-A5DC4D | GenWay Biotech | 0.5 mg | Ask for price |
Linearity FD General Chemistry Panel 1 for Ortho Vitros |
|||
| K900M-5 | Audit MicroControls | 10 x 5 mL* | 350 EUR |
Linearity FD General Chemistry Panel 2 for Ortho Vitros |
|||
| K901M-5 | Audit MicroControls | 5 x 1 mL | 75 EUR |
Linearity FD General Chemistry Panel 3 for Ortho Vitros |
|||
| K902M-5 | Audit MicroControls | 5 x 1 mL | 100 EUR |
Linearity FD General Chemistry Panel 4 for Ortho Vitros |
|||
| K903M-5 | Audit MicroControls | 10 x 2 mL | 343 EUR |
HBsAg adw2 |
|||
| hbs-885 | ProSpec Tany | 10µg | 60 EUR |
|
Description: Recombinant Hepatitis B Surface Antigen Adw2 subtype |
|||
Linearity FLQ General Chemistry Panel 2 for Roche Systems |
|||
| K918M-5 | Audit MicroControls | 5 x 2 mL | 225 EUR |
Linearity FLQ General Chemistry Panel 3 for Roche Systems |
|||
| K919M-5 | Audit MicroControls | 5 x 2 mL | 205 EUR |
Linearity FD General Chemistry Panel 1 for Abbott Systems |
|||
| K940M-5 | Audit MicroControls | 10 x 3 mL | 250 EUR |
Linearity FD General Chemistry Panel 2 for Abbott Systems |
|||
| K941M-5 | Audit MicroControls | 5 x 3 mL | 250 EUR |
Linearity FD General Chemistry Panel 3 for Abbott Systems |
|||
| K942M-5 | Audit MicroControls | 5 x 1 mL | 80 EUR |
Linearity FD General Chemistry Panel 4 for Abbott Systems |
|||
| K943M-5 | Audit MicroControls | 10 x 2 mL | 372 EUR |
HBsAg preS1 |
|||
| hbs-871 | ProSpec Tany | 10µg | 55 EUR |
|
Description: Recombinant Hepatitis B Surface Antigen preS1 |
|||
HBsAg preS2 |
|||
| hbs-874 | ProSpec Tany | 10µg | 55 EUR |
|
Description: Recombinant Hepatitis B Surface Antigen preS2 |
|||
HBsAg Serum Test Card |
|||
| HBsAg-212 | Innovation Biotech | 4.0mm (strip in a card) 25cards/box | 0.16 EUR |
HBsAg Paired |
|||
| ant-650 | ProSpec Tany | 100µg | 165 EUR |
|
Description: Mouse Anti Hepatitis B Surface Antigen Paired |
|||
HBsAg Serum Test Strip |
|||
| HBsAg-211 | Innovation Biotech | 3.0mm (single pouch) 100pouches/box | 0.08 EUR |
HBsAg Protein |
|||
| abx060551-1mg | Abbexa | 1 mg | 1863.6 EUR |
HBsAg Protein |
|||
| abx060552-1mg | Abbexa | 1 mg | 1212 EUR |
HBsAg Protein |
|||
| abx060560-1mg | Abbexa | 1 mg | 1345.2 EUR |
HBsAg Protein |
|||
| abx060562-1mg | Abbexa | 1 mg | 1880.4 EUR |
HBsAg antibody |
|||
| 10-1323 | Fitzgerald | 1 mg | 98 EUR |
|
Description: Mouse monoclonal HBsAg antibody |
|||
HBsAg antibody |
|||
| 10-1324 | Fitzgerald | 1 mg | 98 EUR |
|
Description: Mouse monoclonal HBsAg antibody |
|||
HBsAg antibody |
|||
| 10-2875 | Fitzgerald | 1 mg | 200 EUR |
|
Description: Monoclonal anti-HBsAg antibody |
|||
HBsAg antibody |
|||
| 10-3128 | Fitzgerald | 1 mg | 204 EUR |
|
Description: Mouse Monoclonal HBsAg antibody |
|||
HBsAg antibody |
|||
| 10-3130 | Fitzgerald | 1 mg | 204 EUR |
|
Description: Mouse Monoclonal HBsAg antibody |
|||
HBsAg antibody |
|||
| 10-3131 | Fitzgerald | 1 mg | 204 EUR |
|
Description: Mouse Monoclonal HBsAg antibody |
|||
HBsAg antibody |
|||
| 10-7857 | Fitzgerald | 1 mg | 255 EUR |
|
Description: Mouse monoclonal HBsAg antibody |
|||
HBsAg antibody |
|||
| 10-7858 | Fitzgerald | 1 mg | 250 EUR |
|
Description: Mouse monoclonal HBsAg antibody |
|||
HBsAg antibody |
|||
| 10-H05A | Fitzgerald | 1 mg | 176 EUR |
|
Description: Mouse monoclonal HBsAg antibody |
|||
HBsAg antibody |
|||
| 10-H05B | Fitzgerald | 1 mg | 176 EUR |
|
Description: Mouse monoclonal HBsAg antibody |
|||
HBsAg antibody |
|||
| 10-H05C | Fitzgerald | 1 mg | 582 EUR |
|
Description: Mouse monoclonal HBsAg antibody |
|||
HBsAg antibody |
|||
| 10-H05D | Fitzgerald | 1 mg | 176 EUR |
|
Description: Mouse monoclonal HBsAg antibody |
|||
HBsAg antibody |
|||
| 10-H05F | Fitzgerald | 1 mg | 176 EUR |
|
Description: Mouse monoclonal HBsAg antibody |
|||
HBsAg antibody |
|||
| 10-H05G | Fitzgerald | 1 mg | 197 EUR |
|
Description: Mouse monoclonal HBsAg antibody |
|||
HBsAg antibody |
|||
| 10-H05H | Fitzgerald | 1 mg | 197 EUR |
|
Description: Mouse monoclonal HBsAg antibody |
|||
HBsAg antibody |
|||
| 10-H05J | Fitzgerald | 1 mg | 150 EUR |
|
Description: Mouse monoclonal HBsAg antibody |
|||
HBsAg antibody |
|||
| 10-H05N | Fitzgerald | 1 mg | 176 EUR |
|
Description: Mouse monoclonal HBsAg antibody |
|||
HBsAg antibody |
|||
| 10-H114C | Fitzgerald | 1 mg | 272 EUR |
|
Description: Mouse monoclonal HBsAg antibody |
|||
HBsAg antibody |
|||
| 10-H114D | Fitzgerald | 1 mg | 262 EUR |
|
Description: Mouse monoclonal HBsAg antibody |
|||
HBsAg antibody |
|||
| 10R-H114c | Fitzgerald | 1 mg | 409 EUR |
|
Description: Mouse monoclonal HBsAg antibody |
|||
HBsAg antibody |
|||
| 10R-H114d | Fitzgerald | 1 mg | 393 EUR |
|
Description: Mouse monoclonal HBsAg antibody |
|||
HBsAg antibody |
|||
| 10C-CR1279M1 | Fitzgerald | 100 ug | 337.2 EUR |
|
Description: Mouse monoclonal HBsAg antibody |
|||
HBsAg antibody |
|||
| 20-HR20 | Fitzgerald | 1 mg | 425 EUR |
|
Description: Rabbit polyclonal HBsAg antibody |
|||
HbsAg antibody |
|||
| 20R-2830 | Fitzgerald | 1 ml | 678 EUR |
|
Description: Goat polyclonal HbsAg antibody |
|||
HBsAg antibody |
|||
| 20C-CR2100G | Fitzgerald | 1 ml | 95 EUR |
|
Description: Goat polyclonal HBsAg antibody |
|||
HBsAg antibody |
|||
| 20C-CR2100GP | Fitzgerald | 1 ml | 360 EUR |
|
Description: Goat polyclonal HBsAg antibody |
|||
HBsAg Antibody |
|||
| E3M00015 | EnoGene | 200ul | 275 EUR |
|
Description: Available in various conjugation types. |
|||
HBsAg antibody |
|||
| 70-1088 | Fitzgerald | 1 mg | 175 EUR |
|
Description: Goat polyclonal HBsAg antibody |
|||
HBsAg antibody |
|||
| 70-HH15 | Fitzgerald | 1 mg | 190 EUR |
|
Description: Horse polyclonal HBsAg antibody |
|||
HBsAg antibody |
|||
| 70R-HG003 | Fitzgerald | 1 mg | 200 EUR |
|
Description: Goat polyclonal HBsAg antibody |
|||
HBsAg Antibody |
|||
| GWB-3BB8FC | GenWay Biotech | 1 mg | Ask for price |
HbsAg Antibody |
|||
| GWB-407BB6 | GenWay Biotech | 0.25 mg | Ask for price |
HBsAg Antibody |
|||
| GWB-53EA2F | GenWay Biotech | 1 mg | Ask for price |
HBsAg Antibody |
|||
| GWB-24211C | GenWay Biotech | 1 mg | Ask for price |
HBsAg Antibody |
|||
| GWB-8BE4A9 | GenWay Biotech | 1 mg | Ask for price |
HBsAg Antibody |
|||
| GWB-79EB6C | GenWay Biotech | 1 mg | Ask for price |
HBsAg antibody |
|||
| MBS831541-1mg | MyBiosource | 1mg | 305 EUR |
HBsAg antibody |
|||
| MBS831541-5x1mg | MyBiosource | 5x1mg | 1230 EUR |
HBsAg antibody |
|||
| MBS830186-1mg | MyBiosource | 1mg | 305 EUR |
HBsAg antibody |
|||
| MBS830186-5x1mg | MyBiosource | 5x1mg | 1230 EUR |
HBsAg Antibody |
|||
| MBS186001-1mg | MyBiosource | 1mg | 205 EUR |
HBsAg Antibody |
|||
| MBS186001-2x1mg | MyBiosource | 2x1mg | 285 EUR |
HBsAg Antibody |
|||
| MBS186001-5x1mg | MyBiosource | 5x1mg | 625 EUR |
HBsAg Antibody |
|||
| MBS186002-INQUIRE | MyBiosource | INQUIRE | Ask for price |
HBsAg Antibody |
|||
| MBS186003-INQUIRE | MyBiosource | INQUIRE | Ask for price |
HBsAg Antibody |
|||
| MBS186004-INQUIRE | MyBiosource | INQUIRE | Ask for price |
HBsAg Antibody |
|||
| MBS186287-1mg | MyBiosource | 1mg | 205 EUR |
HBsAg Antibody |
|||
| MBS186287-2x1mg | MyBiosource | 2x1mg | 285 EUR |
HBsAg Antibody |
|||
| MBS186287-5x1mg | MyBiosource | 5x1mg | 625 EUR |
HBsAg Antibody |
|||
| MBS186288-1mg | MyBiosource | 1mg | 205 EUR |
HBsAg Antibody |
|||
| MBS186288-2x1mg | MyBiosource | 2x1mg | 285 EUR |
HBsAg Antibody |
|||
| MBS186288-5x1mg | MyBiosource | 5x1mg | 625 EUR |
HBsAg antibody |
|||
| MBS530110-1mg | MyBiosource | 1mg | 280 EUR |
HBsAg antibody |
|||
| MBS530110-5x1mg | MyBiosource | 5x1mg | 1115 EUR |
HBsAg antibody |
|||
| MBS531485-1mg | MyBiosource | 1mg | 280 EUR |
HBsAg antibody |
|||
| MBS531485-5x1mg | MyBiosource | 5x1mg | 1115 EUR |
HBsAg antibody |
|||
| MBS531522-1mg | MyBiosource | 1mg | 570 EUR |
HBsAg antibody |
|||
| MBS531522-5x1mg | MyBiosource | 5x1mg | 2410 EUR |
HBsAg antibody |
|||
| MBS531766-1mg | MyBiosource | 1mg | 305 EUR |
HBsAg antibody |
|||
| MBS531766-5x1mg | MyBiosource | 5x1mg | 1220 EUR |
HBsAg antibody |
|||
| MBS531825-1mg | MyBiosource | 1mg | 305 EUR |
HBsAg antibody |
|||
| MBS531825-5x1mg | MyBiosource | 5x1mg | 1220 EUR |
HBsAg antibody |
|||
| MBS532465-1mg | MyBiosource | 1mg | 255 EUR |
HBsAg antibody |
|||
| MBS532465-5x1mg | MyBiosource | 5x1mg | 995 EUR |
HBsAg antibody |
|||
| MBS530171-1mg | MyBiosource | 1mg | 280 EUR |
HBsAg antibody |
|||
| MBS530171-5x1mg | MyBiosource | 5x1mg | 1115 EUR |
HBsAg antibody |
|||
| MBS530326-1mg | MyBiosource | 1mg | 1015 EUR |
HBsAg antibody |
|||
| MBS530326-5x1mg | MyBiosource | 5x1mg | 4420 EUR |
HBsAg antibody |
|||
| MBS530563-1mg | MyBiosource | 1mg | 280 EUR |
HBsAg antibody |
|||
| MBS530563-5x1mg | MyBiosource | 5x1mg | 1115 EUR |
HBsAg antibody |
|||
| MBS530892-1mg | MyBiosource | 1mg | 585 EUR |
HBsAg antibody |
|||
| MBS530892-5x1mg | MyBiosource | 5x1mg | 2485 EUR |
HBsAg antibody |
|||
| MBS533975-1mg | MyBiosource | 1mg | 305 EUR |
HBsAg antibody |
|||
| MBS533975-5x1mg | MyBiosource | 5x1mg | 1230 EUR |
HBsAg antibody |
|||
| MBS534244-1mg | MyBiosource | 1mg | 325 EUR |
HBsAg antibody |
|||
| MBS534244-5x1mg | MyBiosource | 5x1mg | 1305 EUR |
HBsAg antibody |
|||
| MBS534777-INQUIRE | MyBiosource | INQUIRE | Ask for price |
HBsAg antibody |
|||
| MBS535105-1mg | MyBiosource | 1mg | 315 EUR |
HBsAg antibody |
|||
| MBS535105-5x1mg | MyBiosource | 5x1mg | 1265 EUR |
HBsAg antibody |
|||
| MBS536109-1mL | MyBiosource | 1mL | 200 EUR |
HBsAg antibody |
|||
| MBS536109-5x1mL | MyBiosource | 5x1mL | 740 EUR |
HBsAg antibody |
|||
| MBS536297-1mL | MyBiosource | 1mL | 530 EUR |
HBsAg antibody |
|||
| MBS536297-5x1mL | MyBiosource | 5x1mL | 2235 EUR |
ELISA kit for Human Hepatitis B surface antigen (HBsAg) Kit |
|||
| KTE63050-5platesof96wells | Abbkine | 5 plates of 96 wells | 2702.4 EUR |
|
Description: Quantitative sandwich ELISA for measuring Human Hepatitis B surface antigen (HBsAg) Kit in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids. |
|||
Mixed Titer Bacteria Panel for Platelets (12 Samples 0.1 mL) |
|||
| 820000 | Zeptometrix | 12 Samples 0.1 mL | 488 EUR |
Mixed Titer Bacteria Panel for Platelets (12 Samples 0.1 mL) |
|||
| 0820000 | Zeptometrix | - | 488 EUR |
Inhibition Control for EZ‐Series Assay |
|||
| TC-9110-001 | Tetracore | each | 75 EUR |
ELISA kit for Human hepatitis B virus surface antigen,HBsAg |
|||
| EK0216 | SAB | 96 tests | 723.6 EUR |
|
Description: Enzyme-linked immunosorbent assay kit for quantification of Human hepatitis B virus surface antigen,HBsAg in samples from serum, plasma, tissue homogenates and other biological fluids. |
|||
ELISA kit for Mouse hepatitis B virus surface antigen,HBsAg |
|||
| EK0341 | SAB | 96 tests | 996 EUR |
|
Description: Enzyme-linked immunosorbent assay kit for quantification of Mouse hepatitis B virus surface antigen,HBsAg in samples from serum, plasma, tissue homogenates and other biological fluids. |
|||
ELISA kit for Canine hepatitis B virus surface antigen,HBsAg |
|||
| EK0029 | SAB | 96 tests | 996 EUR |
|
Description: Enzyme-linked immunosorbent assay kit for quantification of Canine hepatitis B virus surface antigen,HBsAg in samples from serum, plasma, tissue homogenates and other biological fluids. |
|||
Recombinant HBsAg |
|||
| HBSAG-255H | Creative BioMart | 1mg | 3998.4 EUR |
Recombinant HBsAg |
|||
| HBsAg-268H | Creative BioMart | 100ug | 478.4 EUR |
Control for Tyrosinase, 4 cases (1.5mm)HumanskinSkinIHC control |
|||
| TYROSIN081 | Pantomics | 1.5mm | 50 EUR |
MAb to HBsAg |
|||
| MBS313228-1mg | MyBiosource | 1mg | 570 EUR |
MAb to HBsAg |
|||
| MBS313228-5x1mg | MyBiosource | 5x1mg | 2385 EUR |
MAb to HBsAg |
|||
| MBS310430-1mg | MyBiosource | 1mg | 525 EUR |
MAb to HBsAg |
|||
| MBS310430-5x1mg | MyBiosource | 5x1mg | 2185 EUR |
MAb to HBsAg |
|||
| MBS310467-1mg | MyBiosource | 1mg | 525 EUR |
MAb to HBsAg |
|||
| MBS310467-5x1mg | MyBiosource | 5x1mg | 2185 EUR |
MAb to HBsAg |
|||
| MBS310468-1mg | MyBiosource | 1mg | 940 EUR |
MAb to HBsAg |
|||
| MBS310468-5x1mg | MyBiosource | 5x1mg | 4045 EUR |
MAb to HBsAg |
|||
| MBS311723-1mg | MyBiosource | 1mg | 515 EUR |
MAb to HBsAg |
|||
| MBS311723-5x1mg | MyBiosource | 5x1mg | 2140 EUR |
Goat IgG (-ve control for flow cytometry) (isotype control) |
|||
| 20011-100 | Alpha Diagnostics | 100 test | 123.6 EUR |
BSA Control for Age-BSA |
|||
| 2221-BSA | Biovision | each | 210 EUR |
BSA Control for AGE-BSA |
|||
| 35R-AA007 | Fitzgerald | 10 mg | Ask for price |
|
Description: BSA Control for AGE protein (BSA modified), Cat No. 30R-AA007 |
|||
HBsAg adw CHO |
|||
| hbs-001 | ProSpec Tany | 100µg | 200 EUR |
|
Description: Recombinant Hepatitis B Surface Antigen Adw subtype, CHO |
|||
HBsAg adr CHO |
|||
| hbs-875 | ProSpec Tany | 20µg | 60 EUR |
|
Description: Recombinant Hepatitis B Surface Antigen adr subtype, CHO |
|||
Control for Mammaglobin, 4 cases (1.5mm)HumanBreastBreastIHC control |
|||
| MAMA-G081 | Pantomics | 1.5mm | 50 EUR |
Recombinant FMD serotype O, 3C protein control for western blot |
|||
| FMDO3C11-C | Alpha Diagnostics | 100 ul | 343.2 EUR |